GH:NASDAQ
Guardant Health Inc
$159.03
arrow_downward
-2.30%(-3.75) 1D
$159.00
arrow_downward
-0.02% (-0.030)todayPre-market
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$159.52
High
$164.17
Low
$156.32
Mkt. cap
21.34B
Avg. vol.
2.14M
Volume
355.00
52-wk high
$176.58
52-wk low
$53.40
EPS
-$3.50
Beta
1.57
Shares outstanding
134.20M
No. of employees
2K
Open
$159.52
High
$164.17
Low
$156.32
Mkt. cap
21.34B
Avg. vol.
2.14M
Volume
355.00
52-wk high
$176.58
52-wk low
$53.40
EPS
-$3.50
Beta
1.57
Shares outstanding
134.20M
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
17 hours ago
Did WCLC Research Push Just Shift Guardant Health (GH) Stock Narrative?
Investing.com
·
21 hours ago
Bernstein reiterates Guardant Health stock rating on margin outlook
Stock Titan
·
1 day ago
Twenty presentations will explore blood tests for lung cancer in Seoul
Yahoo Finance
·
2 days ago
What Makes Guardant Health (GH) a Compelling Bet?
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth care provider
Websiteguardanthealth.com